peiminine has been researched along with Colorectal Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Qin, Y; Wang, W; Yang, K; Zhang, M | 1 |
| He, Q; Li, W; Rao, J; Shen, Q; Tou, F; Xu, L; Zhang, S; Zheng, Z | 1 |
| Chen, X; Lyu, Q; Su, H; Tou, F; Wu, X; Zheng, Z | 1 |
3 other study(ies) available for peiminine and Colorectal Cancer
| Article | Year |
|---|---|
Peiminine inhibits the progression of colorectal cancer through up-regulating miR-760 via declining the expression of long noncoding RNA LINC00659.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cevanes; Colorectal Neoplasms; Disease Progression; Down-Regulation; Male; Mice; MicroRNAs; Real-Time Polymerase Chain Reaction; RNA, Long Noncoding; Up-Regulation | 2021 |
Peiminine inhibits colorectal cancer cell proliferation by inducing apoptosis and autophagy and modulating key metabolic pathways.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cevanes; Colorectal Neoplasms; Energy Metabolism; HCT116 Cells; Humans; Metabolic Networks and Pathways; Metabolome; Metabolomics; Mice | 2017 |
The natural product peiminine represses colorectal carcinoma tumor growth by inducing autophagic cell death.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Biological Products; Cevanes; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; HCT116 Cells; HeLa Cells; Humans; Immunoblotting; Immunohistochemistry; Mice, Inbred BALB C; Mice, Nude; Microscopy, Confocal; Molecular Structure; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |